MSK Exam 2 Flashcards

1
Q

axonal peripheral nerve disease characteristics

A

lower density of axons
degeneration of axons
regeneration/sprouting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

demyelination peripheral nerve disease characteristics

A

axons without myelin
evidence of remyelination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

inflammatory peripheral nerve disease characteristics

A

inflammatory cells
demyelination>axonal degeneration
ascending paralysis
often recovery w support
-conditions: Geuillian Barre, CIPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

infection peripheral nerve disease characteristics

A

acid fast bacilli
granulomas (occassional)
symmetric polyneuropathy (worse in extremities and face due to temperature
-infections: leprosy, herpes simplex, varicella zoster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

metabolic peripheral nerve disease characteristics

A

axonal degeneration and/or demyelination
thickened blood vessels
-conditions: diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

toxic peripheral nerve disease characteristics

A

axonal degeneration and/or demyelination
few with characteristic findings
history often vital
-causes: alcohol, toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

vascular peripheral nerve disease characteristics

A

inflammation or blood vessels with/without necrosis
systemic conditions that affect the nerves
-conditions: vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

genertic peripheral nerve disease characteristics

A

hypertrophic nerves with onion bulbs, leads to palpable nerves
-conditions: charcot marie tooth, dejerine sottas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

conduction velocity tests for neuromuscular diseases

A

slower conduction = demyelination
weaker stimulation = axonal degeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

skeletal muscle structures

A

sarcolemma
T tubules
sarcoplasmic reticulum
mitochondria
myofibrils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

1 muscle fiber innervated by what

A

1 alpha motor neuron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1 motor neuron does what and innervates how many muscle fibers

A

branches and innervates several fibers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

motor unit

A

all the muscle fibers innervated by branches of the same motor neuron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

muscle tension strength increased by what

A

recruitment of additional motor units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

timing and sequence of motor unit recruitment controlled from what

A

cerebral motor cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

secretion of ACh steps

A

action potential causes opening of voltage gated Ca channels which lets Ca enter the presynaptic terminal causing release of ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ACh receptor channels located where

A

top of subneural cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

voltage gated Na channes where

A

along the sarcolemma incuding the T tubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

post synaptic ACh receptors

A

nicotinic ACh receptors allow passage of NA and K
driving force of Na influx creates end plate potential (EPP)
usually EPP reaches threshold and initiates an AP that spreads through sarcolemma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ACh removed how

A
  1. acetylcholinesterase
  2. diffuse out of synaptic space and no longer available to act on the muscle fiber
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what carries the AP to the sarcoplasmic reticulum

A

t tubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what happens when the AP reaches the sarcoplasmic reticulum

A

AP reaches t tubule
depolarization activates Dihydropyridine receptors (DHP)
DHP triggers opening of mechanically linked ryanodine receptors on SR
ryanodine receptor opening allows Ca out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

thin filaments

A

actin, tropomyosin, troponin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

actin structure

A

backbone is double stranded F actin
each F is composed of G actin
each G actin has myosin head binding sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
tropomyosin structure
regulatory protein blocks myosin binding sites on actin
26
troponin
regulatory protein t - bind tropomyosin c - bind calcium i - bind actin and inhibit contraction
27
thick filament
myosin
28
myosin structure
heavy chains : 2, wrap spirally around each other, rod/hinge/head, head has binding site for actin and binding site for ATP (myosin ATP ase) light chains : 4, stabilizes myosin head, regulate ATPase activity
29
what role does calcium play in sliding filament theory
troponin must bind calcium to induce conformation change of tropomyosin to reveal binding sites for mysoin heads once attached myosin does the power stroke, pulling actin along (sliding)
30
sarcomere structure
nebulin - aligns thin filaments titin - helps thick filament return to original position after contraction z disk - where thin filaments attach (seperates sarcomeres) i band - contains only thin filaments a band - contains all the thick filament h band - only the thick filament in the center m line - attachment for thick filament
31
how many thin filaments are each thick filament surrounded by
6
32
how many thick filaments are each thin filament surrounded by
3
33
what happens to the components of the sarcomere in contraction
z disks move toward one another I band shortens H band shortens A band remains unchanged
34
contraction cycle
ATP binds myosin (causing it to release actin) APT immediately hydrolyzes ATP into ADP and Pi conformational change in myosin rotates the head (waiting for calcium release) Ca binds troponin tropomysin complex letting myosin firmly bind and power stroke occurs (head rotates pulling actin with it) once head tilts ADP is released and binding of ATP releases actin
35
power stroke
during contraction while one myosin head dissociating another head is performing the powerstroke so actin doesnt slip
36
the greater number of cross bridges in contact with actin
the stronger the force of contraction
37
rigor mortis
no ATP to bind myosin and release actin
38
lambert eaton myasthenic syndrome
autoimmune atttack against voltage gated calcium channels on presynapic terminal weak end plate potential
39
myasthenia gravis
autoimmune disease characterized by presence of antibodies against nicotinic ACh receptor weak end plate potentials
40
botulism
botulinum toxin decreases release of ACh by cleaving proteins in the vesicle
41
muscular dystrophy
duchenne - absent or tuncated dystrophin becker - dystrophin present but less functional
42
malignant hyperthermia
constant leak of SR Ca through ryanodine receptor triggered by anesthetics complications - rhabdomyolysis and hyperkalemia treatment - cooling and dantrolene (ryanodine receptor antagonist)
43
relaxation phase of skeletal muscle contraction
voltage change closes DHP receptors closing ryanodine receptors Ca pumped back into SR using Ca ATPase (SERCA) as Ca decreases more dissociates from troponin C, tropomyosin slides back to block myosin crossbridges break and myosin returns to relaxed position (with help of titin)
44
isometric contraction
length remains unchanges but tension increases stretching of elastic elements in tendons
45
isotonic contraction
one point of muscle fixed and other has load added shortening of the muscle if tension greater than the load elastic elements are already stretched so sarcomere shortens concentric - muscle shortens reducing angle eccentric - muscle lengthens while contracting
46
muscle contracts rapidly when
against no load
47
muscle contracts slowly when
against large load
48
power equals what
load x velocity
49
if a second stimulus occurs during a twitch what happens
another contraction occurs before the first contraction is finished
50
summation of contractions
force of contration increases with summation
51
tetanus
muscle stimulated repeatedly so muscle doesnt relax
52
force summation
frequency - increase the frequency a single fiber contracts multiple fiber - increase the number of motor units contracting
53
size principle
progressive recruitment of first small then large fibers
54
slow oxidative (type I) fibers
low myosin ATPase activity, high oxidative capacity dark red smaller fibers innervated by smaller nerves increased mitochondria lots of myoglobin fatigue resistant back muscles/marathon running
55
fast oxidative glycolytic (type 2A) fibers
high myosin ATPase activity with high oxidative capacity and intermediate glycolytic capacity fatigue resistant moderate myoglobin red muscle abundant glycogen and mitochondria standing/walking
56
fast glycolytic (type 2X) fibers
high myosin ATPase activity with high glycolytic capacity rapid forceful movements fewer mitochondria low myoglobin white muscle easily fatigues jumping/sprinting/weightlifting
57
muscle plasticity
exercise training or changes in patterns of neuronal stimulation can cause changes in proportion of slow vs fast twitch muscle fibers
58
smooth muscle unitary structural organization
sheets of electrically coupled cells gap juncts for communication cels contract together - syncytium
59
smooth muscle multiunit structural organization
each cell receives seperate input each can contract independently no gap juncts
60
tonic smooth muscle
usually contracted sphincters
61
phasic smooth muscle
normally relaxed and undergoes rhythmic changes in contractile state stomach and bladder
62
smooth muscle key characteristics
contraction initiated by electrical, chemical, and mechanical input ANS release NT through varicosities Ca from ECF and sarcoplasmic reticulum myosin ATPase only active when phosphorylated
63
spontaneous electrical initiation of smooth muscle contraction
pacemaker activity from channels that spontaneously increase depolarizing currents interstitial cells of cajal in digestive system
64
hormones and paracrine signals of smooth muscle contraction
vasopressin and angiotensin II (vasoconstrictor) NE (vasoconstrictor and vasodilator) histamine (constrict airway) nitric oxide (relax smooth muscle of vessels)
65
how does smooth muscle increase Ca
L type voltage gated calcium channels calcium induced calcium release from SR chemically stimulated IP3 (agonist binding GPCR leads to formation IP3) store operated channels (depletion SR Ca cause aggregation STIM 1 which activates orai channels allowing Ca entry)
66
what allows myosin to bind actin
phosphorylation by myosin light chain kinase
67
MLCK stimulated by what
Ca dependent calmodulin
68
what dephosphorylates myosin and promotes relaxation
myosin light chain phosphorylase
69
smooth muscle contraction stages
increased cytosolic calcium Ca binds calmodulin Ca calmodulin activates myosin light chain kinase phosphorylated MLC triggers conformational change that allows attachment myosin head
70
smooth muscle relaxation
decreased cytosolic calcium (decreased activation MLCK) refilling of SR stores w SERCA sodium calcium exchangers plasma membrane calcium ATPase
71
what second messenger inhibits MLCK
cAMP
72
what second messenger inhibits MLCP
rhokinase
73
cyclic nucleotides favor what
vasodilation NO increases cGMP cGMP increases MLCP activity prostoglandins increase cAMP cAMP inhibit MLCK
74
Ca favors what
constriction Gq IP3 induced Ca release by endothelin and thromboxane extracellular calcium influx
75
vasoconstriction does what
increase BP decrease perfusion
76
vasodilation does what
decrease BP increase perfusion
77
airway smooth muscle changes
cyclic nucleotides favor relaxation Ca favors constriction bronchodilators increase cAMP levels and decrease G mediated Ca increase
78
cardiac muscle contraction
Ca is a mediator and an activator Ca binds troponin revealing binding site Ca influx to cardiomyocytes trigger SR Ca release
79
cardiac muscle relaxation
calcium reuptake into the SR by Ca ATPase (SERCA2) SERCA2 regulated by phospholambin which is regulated by phosphorylation Na Ca exchanger
80
how does cardiac muscle avoid tetanus
duration AP = period of contraction and relaxation
81
increasing endurance capacity
increase type 1 fibers greater oxidative capacity increase oxygen delivery increase capillary supply increase mitochondria content increase glycogen storage
82
strength training
strength of muscle determined by size increase in contractile proteins resistance training amplifies type 2 fibers (rapid forceful movements but fatigue quickly)
83
immediate energy sources for muscles
ATP (1-2s) phosphocreatine (3-5s)
84
nonoxidative/anaerobic glycolysis for muscle energy
1 - 2 minutes uses muscle glucose and glycogen
85
aerobic oxidation for muscle energy
plasma glucose, muscle glycogen, liver glucagon, plasma free fatty acids, adipose triglycerides
86
sustained activity of moderate intensity
use mainly fatty acids and glucose oxidation provides the remainder of the energy
87
in the absence of glucose or triglycerides
proteins utilized for energy for muscles
88
breaking down of proteins promoted by what
glucocorticoids
89
types of muscle fatigue
central peripheral lactic acid accumulation glycogen depletion
90
central fatigue
changes in CNS reduce excitatory input
91
peripheral fatigue
impaired initiation or propogation of AP (impaired membrane excitability or depleted ACh) impaired Ca release accumulation byproducts
92
lactic acid accumulation
decreases pH reduce myosin ATPase activity
93
glycogen depletion
no glycogen for energy carb loading can prevent hitting the wall by increasing resting glycogen stores
94
muscle building
active myocytes promote vasodilation, secrete growth factors (IGF 1/2, FGF), promote satellite cell activation stress of exercise induce sympathetic nervous system and increases cardiac output
95
hypertrophy
caused by near maximal force development increase in myofibrils
96
lengthening
occurs when muscles are stretched new sarcomeres added increase shortening capacity increase contraction velocity
97
hyperplasia
formation new muscle fibers caused by endurance training
98
causes of muscle atrophy
denervation/neuropathy, tenotomy, sedentary life style, cast, space flight
99
effects of muscle atrophy
degeneration of contractile proteins decreased max force of contraction decreased velocity of contraction
100
effects of loss of innervation on muscle
2 months - degenerative changes occur (if returned rapidly full function can return in 3 months w electrical stimulation) 1-2 years muscle fibers are lost and replaced with fibrous and fatty tissue contracture - fibrous tissue replacing muscle fibers shorten
101
depletion of muscle and liver glycogen
increase in muscle catabolism stimulated by glucocorticoids
102
testosterone
protein synthesis via direct and powerful transcriptional effects -loss of muscle with aging
103
estrogen
increased protein assembly via metabolic pathways -loss of muscle post menopause
104
increased glucocorticoids/cortisol
response to stress elevated in many pathologies (cushing syndrome) increased muscle catabolism
105
growth hormone effect on muscle
stimulates IGF release which promotes hypertrophy
106
thyroid hormone effect on muscle
increase muscle contractility, glycolytic capacity, myofibril assembly
107
steps of O2 uptake and consumption
1. uptake of O2 by lungs depends on pulmonary ventilation (VO2 max is point transport system can no longer keep up with demand, O2 uptake plateus) 2. O2 delivery to muscles depends on blood flow and O2 content (increase alveolar ventilation to maintain PO2 levels, increase cardiac output to ensure high flow of blood) 3. extraction of O2 from blood depends on O2 delivery and pressure gradient between blood and mitochondria (training can augment maximal cardiac output)
108
pH 4.6 staining
type 1 dark type 2a pale type 2b intermediate
109
pH 9.4 staining
type 1 light type 2a dark type 2b dark
110
nadh staining
type 1 dark type 2 light
111
succinate dehydrogenase staining
type 1 dark type 2 light
112
COX staining
type 1 darker type 2 lighter
113
neurogenic muscle disease characteristics
distal>proximal weakness atrophic fibers (denervated) and type grouping
114
myopathic muscle disease characteristics
increased internal nuclei degenerating/regenerating fibers proximal>distal weakness
115
types of neuromuscular diseases
myasthenia gravis lambert eaton syndrome
116
myasthenia gravis
antibodies again post synaptic ACh receptors with loss of receptors increased weakness with repetitive stimulation can occur w thymomas
117
lambert eaton syndrome
antibodies again presynaptic voltage gated calcium channels increased strength with nerve stimulation can be paraneoplastic
118
types of myogenic muscular diseases
inflammatory (polymyositis, dermatomyositis, inclusion body myositis) dystrophic (dystrophinopathy, limb girdle, myotonic dystrophy) metabolic (McArdle, lipid myopathies, mitochondrial myopathies) congenital (floppy babby) drug/toxic (corticosteroids, statins) systemic disease
119
inflammatory muscle disease characteristics
internal nuclei, inflammation, myophagocytosis, degenerating and regenerating fibers antibodies (anti-Jo-1) may be present
120
polymyositis
wide spread changes throughout the involved muscle responds to steroids increased serum creatine kinase
121
dermatomyositis
inflammation (perivascular), perifasicular atrophy, skin changes responsive to steroids
122
inclusion body myositis
cytoplasmic inclusions, rimmed vacuoles not responsive to steroids
123
dystrophic muscle disease characteristics
can be genetic wide spread variation in fiber size including hypertrophic fibers
124
dystrophinopathy
absence (duchene) or irregular (becker) staining for dystrophin X linked produces cardiac manifestations hypertrophy of calf muscles secondary to fatty replacement of fibers
125
limb girdle
autosomal inheritance prob with dystrophic associated proteins similarities w muscular dystrophy
126
myotonic dystrophy
CTG repeats large increased internal nuclei muscles inable to relax cataracts, baldness, gonadal atrophy
127
metabolic muscle disease characteristics
secondary to enzyme/genetic issue often related to energy stores
128
McArdle
deficiency of phosphorylase difficult cleaving glucose molecules from glycogen difficulty w exercise
129
lipid myopathies
accumulation lipids
130
mitochondrial myopathies
abnormal mitochondria abnormal staining mitochondrial enzymes include MELAS, Kearns Sayre, MERRF
131
congenital muscle disease (floppy baby)
nemaline rod (accumulation z band material) centronuclear central core myopathies
132
corticosteroid muscle disease
type 2 fiber atrophy
133
statins muscle disease
myalgia, mitosis, rhabdomyolosis, vacuolization
134
skeletal muscle nuclei
in peripheral
135
cardiac muscle nuclei
central
136
smooth muscle nuclei
random
137
what percentage of internal nuclei are typically seen in normal muscle
4%
138
hemiplegic gate
loss of normal arm swing
139
diplegic gait
spasticity in lower extremities worse than upper extremities
140
neuropathic (steppage) gait
patients with foot drop
141
myopathic (waddling) gait
hip girdle weakness drop in pelvis on contralateral side of pelvis while walking (trendelenburg)
142
choreiform gait (hyperkinetic)
irregular, jerky, incoluntary movements in all extremities
143
ataxic gait
staggering movements with wide based gait
144
parkinsonian gair
slow little steps
145
spurlings test
extend neck and sidebend head toward affected side, place axial pressure positive is radicular arm pain reproduced cervical radiculopathy
146
bakodys sign
externally rotate and abduct ipsilateral arm and shoulder above patients head relief of pain is positive cervical radiculopathy
147
hoffmans sign
flick tip of middle fingernail positive is thumb flexion spinal cord lesion/pathology of neck region
148
babinski reflex
trace curve of sole of foot positive is hallux extension spinal cord lesion
149
supracondylar humerus fracture
type 1 - fracture but no gaps in bone type 2 - fracture and some gapping/displacement type 3 - complete split of bone and kinked brachial artery fail to treat correctly can lead to volkmanns ischemic contracture
150
in toeing
metatarsal adductus, internal tibial torsion anteversion of humeral head PT, serial casting, shoes/braces, sx
151
kocher criteria
for child with painful hip (non weight bearing on affected side, ESR >40 mm/hr, WBC >12000, fever) 4/4 99% chance septic arthritis 3/4 93% chance septic arthritis 2/4 40% chance septic arthritis 1/4 3% chance septic arthritis
152
congenital hip dislocation
barlow - dislocates ortolani - lying in dislocated position and can be manually reduced use brace
153
club foot (talipes equino varus)
tx - manipulation, serial casting, posteomedial release
154
congenital scoliosis
embryologic complications renal/cardiac issues
155
neuromuscular scoliosis
caused by upper or lower motor neuron lesion during growth can be long c shape
156
degenerative scoliosis
common in elderly loss of disc and joint integrity may lead to loss of disc height asymmetrically and result in loss of coronal and sagital balance
157
idiopathic scoliosis
infantile <3 years juvenile 3-10 years adolescent 10-18 years usually family history, more girls than boys <30 degrees at maturity rarely progress significantly >80 degrees increase risk of shortness of breath curve between 25-40 degrees (reisser 2 or less) can brace >45 degrees can do surgery
158
reisser classification
assess bone maturity by looking at ossification of iliac crest 0 - no ossification 5 - complete ossification (curve >30 before peak growth or while at reisser 0 will most likely need surgery)
159
cobb angle
used to determine degree of scoliosis curve draw line from most tilted superior vertebra and most tilted inferior vertebra, perpendicular lines drawn from both of these creating the cobb angle
160
septic arthritis
most <5 yrs infants - hip most common other joints - knees, ankles, elbows, shoulders, wrist radiographic findings normal early in the course of the disease
161
slipped capital femoral epiphysis
adolescent, more often male and obese usually unilateral mechanical and hormone related AP and lateral films (step off seen on affected hip) immediate non weight bearing and surgery to insert a screw
162
spiral/toddlers fracture
usually <11 years distal 2/3 of tibia closed reduction and short leg casting for 4-6 weeks
163
osteosarcoma
most common primary bone tumor <40 years occur at onset of puberty in long bones of lower extremities pain with activity surgery, chemo, radiation
164
legg calve perthes
ischemic necrosis, collapse, and repair of femoral head caused by disruption of blood flow to femoral head 4-8 years and usually boys thigh, hip, or knee pain decreased hip abduction, internal rotation, slight leg length discrepancy braces/surgery, ROM therapy
165
compartment syndrome
increased pressure in limited space compromises circulation and function of muscles and nerves causes - fracture, reperfusion injury, crush injury, animal bites, trauma symps - sever pain and tense swollen compartments increased serum creatine kinase and motor deficits indicate irreversible damage children - analgesia, anxiety, agitation adults - pain, palor, paresthesia, pulselessness, paralysis remove restrictive casts, place limb at heart level, surgical fasciotomy
166
polymyalgia rheumatica
muscle inflammatory condition >50 years bilateral shoulder pain and stiffness, pelvic girdle pain onset acute and symptoms worse in morning association with giant cell arteritis elevated ESR and CRP tx - steroids
167
fibromyalgia
chronic pain disorder w widespread musculoskeletal pain, fatigue, sleep disturbances, headaches, cognitive/mood disturbances usually starts after a stressor initially pain isolated to shoulder no cure, use antidepressants, anti seizure drugs, therapy, aerobic activity, OMT
168
glucocorticoid
any substance, usually a steroid, that activates a glucocorticoid receptor
169
where are natural glucocorticoids made
adrenal glands
170
what controls the release of glucocorticoids
HPA axis (hypothalamus anterior pituitary)
171
effects of glucocorticoids
stimulate gluconeogenesis, decrease utilization glucose, elevate blood glucose reduce cellular protein, liver protein enhanced, increase blood AAs metabolize fatty acids from adipose, excess causes fat redistribution
172
short acting glucocorticoids
hydrocortisone cortisone
173
intermediate acting glucocorticoids
prednisone prednisolone methylprednisolone triamcinolone
174
long acting glucocorticoids
paramethasone betamethasone dexamethasone
175
use of glucocorticoids
reduce inflammation suppress immune response reduce nausea and vomiting reduce terminal pain replacement therapy
176
replacement therapy
same as biological dose hydrocortisone, prednisone, prednisolone
177
anti inflammatory
4x replacement dose prednisone, prednisolone
178
inhibit immune response
16x replacement dose prednisone, prednisolone
179
antiinflammatory action of glucocorticoids
modulate inflammatory response by suppressing expression of proinflammatory cytokines repress expression adhesion molecules induce expression of annexin 1 (promotes neutrophil detachment and apoptosis) switch resident macrophage gene expression to anti inflammatory (increase phagocytic activity) act on t cells blocking th1 and th2 cytokine production and induce cell death
180
glucocorticoid effects on gene transcription
bind and block promoter sites of inflammatory genes (IL1, IL1 beta) activate anti inflammatory genes (IkappaBalpha, IL1receptor2, lipocortin 1, annexin 1, IL10) inhibit synthesis of cytookines (NF kB, AP1)
181
glucocorticoid side effects
rise in blood neutrophils cushing syndrome thin skin osteoporosis immune suppression hyperglycemia
182
kinetics of glucocorticoids
90% bound in blood transport into cells bind glucocorticoid receptor active transport of dimer to nucleus activating gene sequences increase or decrease transcription
183
glucocorticoid resistance
HPA axis receptor downregulation heat shock protein complex redesign Co Activators
184
glucocorticoid contraindications
peptic ulcers, hypertension and diabetes, viral and fungal infections, tuberculosis, osteoporosis, epilepsy and psychosis, CHF and renal failure
185
DMARDs definition
disease modifying antirheumatic drugs
186
conventional synthetic dmards
methotrexate hydroxychloroquine sulfasalazine leflunomide azathioprine
187
biologic dmards
anti TNF alpha - etanercept, adalimumab, certolizumab pegol, goligumab, inflixumab immune cell targets - abatacept, rituximab IL receptor antagonists - tocilizumab, sarilumab, anakinra
188
targeted synthetic DMARDs
JAK inhibitors - tofacitinib, baricitinib
189
bridge therapies
used in conjunction w dmards use while waiting for dmard to become effective or experiencing flares NSAIDS - mild to moderate flares corticosteroids - moderate to severe flares
190
mild to moderate RA
csDMARDs
191
moderate to severe RA
csDMARDs or bDMARDS or csDMARDs+bDMARDs
192
methotrexate
first line, unless low disease activity inhibit AICART which increases adenosine inhibit proliferation and stimulates apoptosis of immune inflammatory cells inhibit proinflammatory cytokines -contraindications: pregnancy, hepatic/renal impairment, bone marrow suppression/aplastic anemia/GI toxicity -adverse effects: nausea, mouth/mucosal ulcers, leukopenia, anemia, ulcerative stomatitis, GI ulceration, alopecia (leucovorin decrease GI side effects)
193
dmard naive with low disease activity
hydroxychloroquine then sulfasalazine then methotrexate then leflunomide
194
uncontrolled disease management
increase dose or switch to another class
195
pretreatment testing
CBC, ESR, CRP, LFT, BUN, creatinine, hep b/c hydroxychloroquine - routine eye exams biologics/jak inhibitors - TB screen JAK inhibitors - lipid panel
196
hydroxychloroquine
stabilize lysosome enzymes, inhibit leukocyte chemotaxis, inhibit rna/dna synth contraindications - cardiomyopathy and QT interval prolongation, cimetidine
197
sulfasalazine
suppress t cell response and inhibit b cell proliferation inhibit release inflammatory cytokines (IL1, IL6, IL12, TNF alpha)
198
leflunomide
pyrimidine antagonist (block DNA synthesis and cell cycling) so arrest lymphocytes in G1 inhibit DHOD inhibit t cell proliferation adverse effects - diarrhea, increased liver enzymes, alopecia, weight gain, contraindicated in pregnancy
199
azathioprine
immunosuppressive antimetabolite SEVERE RA do not use in pregnancy
200
what do they mean?
momab - mouse ximab - chimera zumab - humanized umab - human
201
Anti TNF alpha antibodies MOA
neutralize sTNF, neutralize tmTNF bind tmTNF expressing immune cells and induce apoptosis complement dependent cytotoxicity
202
adverse reactions anti TNF
neutropenia, infections, heart failure, cutaneous reactions
203
infliximab
bind to s and tm TNF downregulation macrophage and t cell function IV infusion increased risk inefction with anakinra or abatacept
204
adalimumab
complexes s TNF and down regulates macrophage and t cell function clearance decreased with methotrexate
205
certolizumab pegol
no fc region, does not fix complement sub q moderate to severe RA w methotrexate
206
golimumab
bind s and tm TNF moderate to severe RA with methotrexate sub q
207
etanercept
binds TNF sub Q do not start in active infection hep b virus for reactivation
208
abatacept
inhibits t cell activation decrease t cell proliferation and inhibit production of cytokines TNF alpha, interferon and interlukin 2 moderate to severe RA increased risk of infection
209
ritixumab
targets CD20 b lymphocytes moderate to severe RA fatal infusion reaction
210
tocilizumab/sarilumab
bind IL6 receptors and inhibit IL6 mediated signaling\adverse effects - upper respiratory infections, headaches, injection site reactions, hypertension, nasopharyngitis, increased ALT, neutropenia, reduced platelets, lipid abnormalities
211
anakinra
bind and inhibit IL1 receptor treat RA pts who have failed 1 or more DMARDs sub Q serious infections can occur
212
tofacitinib/baricitinib
target JAK inhibitor influence transcription of genes that are crucial for differentiation, proliferation, function NK cells and T and B lymphocytes in RA as monotherapy or in combination with methotrexate adverse effects - increased risk of infection, thrombosis, CV death , MI, elevated liver enzymes, GI perforation
213
lateral epicondylitis
pain with wrist or finger extension extensor carpi radialis brevis pain with passive wrist flexion tx - support straps and PT/OT
214
medial epicondylitis
pain with wrist flexion with elbow extended pain with passive wrist extension over head thrower medial ulnar collateral ligament injury should be ruled out flexor pronator strain can be culprit tx - rest, ice, PT, NSAIDs
215
olecranon bursitis
swelling bursa over olecranon usually after trauma, arthritis, or infection common site for rheumatoid nodules or tophi from gout tx - ice, anti inlammatory meds, aspiration/compression
216
nursemaids elbow
children 1-4 years must rule out fracture anular ligament is interposed into radiocapitellar joind reduction with flexion, supination (palpable clunk)
217
cubital tunnel
compressive mononeuropathy, often trauma or prolonged elbow flexion numbness/paresthesia of ulnar nerve tinel test over ulnar groove, nerve conduction studies for definitive diagnosis can result in claw hand tx- splints, avoid provocation, sx
218
carpal tunnel
physical test (durkens compression, phalens, reverse phalens, tinel) nerve conduction studies/electromyelogram for difinitive diagnosis numbness/tingling in lateral hand can result in thenar atrophy
219
dequervains tenosynovitis
entrapment of abductor pollicis longus and extensor pollicis brevis tendons at radial styloid not inflammatory secondary to chronic overuse of wrist finkelsteins test tx - splint, injection
220
triangular fibrocartilage complex
meniscus of wrist injured in ulnar deviation and wrist extension lunate is susceptible to ulnar abutment (can have chronic pain and instability) pinpoint tenderness of ulnar fovea MR arthrogram and wrist arthroscopy to diagnose
221
dupuytrens contracture
fibrosis of palmar fascia due to fibrobastic proliferation and collagen deposition nodules form and lead to contractures tx - collagenase injections, sx
222
trigger finger
stenosing flexor tenosynovitis snapping or catching of finger in flexion discomfort in finger but stenosing occurs more proximally tx - injections, sx, consider getting A1c, DO NOT SPLINT
223
scaphoid fracture
FOOSH pain over anatomical snuffbox x ray (if initially negative brace and reevaluate in 2 weeks), if pain persists and xray negative consult ortho wrist fusion is unacceptable
224
complex regional pain syndrome
reflex sympathetic dystrophy pain in distal limbs pain, swelling, skin changes often after trauma to extremity increased sensitivity 3 phase bone scan to detect metabolic changes tx - NSAIDs, anticonvulsants, antidepressants, regional nerve blocks
225
avascular necrosis of hip
osteonecrosis/aseptic necrosis compromise of vasculature to bone pain in groin, but, thigh (worse w weight bearing) radiograph shows classic crescent sign tx - conservative care and sx
226
meralgia paresthetica
lateral femoral cutaneous nerve entrapment as it passes under inguinal ligament obesity, pregnancy, diabetes burning pain, tingling, deminished sensation on lateral thigh tx - avoid constrictive clothing, weight loss, OMT, PT, NSAIDs (refreactory cases can use anticonvulsants)
227
snapping hip syndrome
snap with mvmt of hip with or without pain common in athletes external most common (mvmt glut max tendon, tensor fascia latae, IT band internal usually w flexion abduction and external rotation tx- OMT, PT could be labral tear of hip
228
trochanteric bursitis
pain over lateral hip over greater trochanter pain when laying on side of bursitis and with activity resist abduction can have antalgic gate tx - NSAIDs, activity moification and exercises, steroid injection could also be IT band syndrome, lumbar radiculopathy, hip nail could cause bursitis
229
piriformis syndrome
entrapment of sciatic nerve often in sprinters and runners buttock pain that increases with sitting (wallet sign), can have paresthesias frieberg test, pace test tx - OMT, PT, steroid injection
230
psoas syndrome
lower back and pelvic girdle pain, difficulty sitting up straight often in runners, jumpers, or sitting for long periods of time dx - thomas test tx - OMT, PT
231
impingement syndrome
pain w overhead motion, pain at night sleeping on shoulder, pain on internal rotation common after 40 due to partial rotator cuff tear compression of subacromial bursa or rotator cuff tendons neer and hawkins test tx - PT, modify activity, injections, OMT
232
rotator cuff disorders
usually supraspinatus weakness in internal and external rotation empty can test xray to rule out other issues, MRI to confirm tear partial tear - OMT/PT full tear - PT/Sx in most young active pts
233
adhesive capsulitis (frozen shoulder)
constant, deep, poorly localized shoulder pain w worsening pain with motion, often worse at night commonly in diabetics conservative therapy, can do sx
234
labrum tear
acute, history of dislocation, chronic overhead throwing SLAP deep pain in joint, catching and locking of joint obriens test MRI to confirm tx - rest, NSAIDs, PT, OMT, sx
235
biceps tendonitis
inflammed long head of biceps tendon, usually caused by overuse anterior shoulder pain radiating down biceps speed and yergasons test tx - steroid injection, NSAIDs, omt, sx for distal tears
236
AC joint instability/separation
graded 1-6 crossover test tx - conservative tx with sling vs sx
237
patellofemoral pain syndrome
runners knee undersurface of patella pain patella not ride in femoral groove patellar apprehension test, j sign tx - ice, NSAIDs, strengthen and stretch, brace, OMT, sx as last resort
238
neuromuscular blocking drugs
interfere with transmission at neuromuscular end plate without affecting CNS nondepolarizing - long acting (tubocurarine, pancuronium), intermediate acting (vecuronium, rocuronium, atrocurium, cisatrocurium), short acting (mivacurium) depolarizing blockers - succinylcholine excreted by kidney = longer half life eliminated by liver = shorter half life (also most of the intermediate acting)
239
spasmolytic drugs
reduce abnormally elevated muscle tone without paralysis, reduce spasticity in neurologic conditions cns action - baclofen, tizanidine, gabapentine, diazepam acute local spasms - cyclobenzaprine, metaxalone, methocarbamol, carisoprodol, orphenarine muscle action - dantrolene, batulinum toxin
240
nondepolarizing blockade
prevent acetylcholine access to receptor and prevent depolarization and cause neuromuscular paralysis like tubocurarine
241
tubocurarine
prototype receptor blocker side effects - hypotension reversible blockade accomplished w use of AChE inhibitors (neostigmine)
242
depolarizing blockade
succinylcholine persistent depolarization of endplate so much so that it can no longer depolarize and contract
243
succinylcholine
2 ACh molecules bound together diffuses and metabolized by plasma short duration of action used to initiate relaxation and other muscle relaxants used to maintain relaxation adverse effects - hyperalemia, increased gastric and intraocular pressure
244
cisatracurium/atracurium
no ganglion blockade, no cardiac M2 receptor activity, no histamine release intermediate acting nondepolarizing muscle relaxant
245
mivucurium
shortest duration profound histamine release cleared by plasma cholinesterase duration prolonged in renal impairment
246
vecuronium/rocuronium
rocurmonium most used steroid derivates can produce tachycardia causing arrythmias
247
baclofen
orally active GABA mimetic agent reduce spasticity with less sedation than BZD adverse effect is drowsiness
248
tizanidine
alpha 2 adrenoreceptor agonist used for spasticity, muscle cramps, muscle tightness drowsiness, hypotension contraindicated with ciprofloxacin and fluvoxamine
249
gabapentin
centrally active gaba antispasmolytic with multiple sclerosis
250
diazepam
facilitate GABA muscle relaxation and reduce muscle spasms
251
dantrolene
interferes with excitation coupling in muscle fibers (inhibits release of calcium by binding ryanodine receptor) can treat malignant hyperthermia
252
botulinum toxin
prevent ACh release
253
methocarbamol
skeletal muscle relaxation via general CNS depression
254
cyclobenzaprine
reduce tonic somatic motor activity anticholinergic effects
255
metaxalone
disrupt spasm pain spasm cycle
256
carisoprodol
central depressant
257